Pharmaceutical Technology

MAY 11, 2023

The company has an innovative boron medicines pipeline. These medicines are used along with low-energy, safe neutrons to enable BNCT. BNCT begins with the administration of a non-toxic boron medicine to the patient. The medicine accumulates in cancer cells and is quickly cleared from the rest of the body.

Medicine 130

Medicine Business Development Clinical Research Development 130

The Pharma Data

DECEMBER 13, 2020

.–( BUSINESS WIRE )– EdiGene, Inc. which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, today announced the appointment of Bo Zhang, Ph.D., as Head of Business Development. Both will report to Dr. Dong Wei, CEO of EdiGene.

Business Development 40

Business Development Development Gene Editing In-Vivo 40

pharmaphorum

JANUARY 4, 2021

Powering digital medicine platforms with big data and IoT devices ensures clinicians receive access to the entire scope of a patient’s health information while reducing the need for in-person visits and improving patient outcomes. One of the focuses of digital medicine is remote patient monitoring.

Big Data 111

Big Data Medicine Doctors Doctor 111

BioPharma Reporter

MARCH 14, 2022

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Business Development 105

Pharmaceutical Technology

MAY 29, 2023

FivepHusion has collaborated with Treehill Partners and Syneos Health to strategically progress development and commercialisation of its chemotherapeutic formulation Deflexifol in markets across the globe. Syneos will support the commercialisation and clinical development capabilities of FivepHusion.

Business Development 130

Business Development Development Marketing Clinical Development 130

XTalks

MAY 17, 2024

Xtalks spoke with Richard Philipson, MD, Chief Medical Officer (CMO) at Calliditas Therapeutics, a Sweden-based company with full commercial operations in the US focused on developing treatments for rare diseases to learn more about the continuing evolution of rare disease drug development.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

BioSpace

JUNE 29, 2022

Blueprint Medicines announced strategic financing collaborations with Sixth Street and Royalty Pharma for up to $1.25 billion to expand Blueprint's pipeline and pursue business development opportunities.

Marketing 70

Marketing Business Development Medicine Development 70

Drug Discovery World

MAY 31, 2024

Jaguar Health’s out-licensing agreement with Magdalena Biosciences to develop novel, natural prescription medicines derived from plants for mental health indications, has been expanded. ” The US schizophrenia market is projected to grow to $8.06 billion by 2030, according to a market research report by Market Research Future. .

Licensing 59

Licensing Licensing Drugs Medicine 59

Drug Discovery World

APRIL 9, 2024

It features Dr Adriano Flora, Director of Business Development at The Jackson Laboratory (JAX). In this vodcast, he discusses alternatives to non-human primates, the key benefits of this, and what impact will they have on the future of drug development. The latest DDW Sitting Down With sponsored vodcast is now available.

Business Development 52

Business Development Development Drugs Medicine 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Worldwide sourcing and drop-ship of orphan medicines, and. GDP and GMP advisory. Temperature control facilities and supply solutions.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

The Pharma Data

OCTOBER 14, 2020

. Proceeds will fund the Phase III program of apraglutide, a potential best-in-class GLP-2 analog, as well as global commercialization and business development activities. Phase II studies of apraglutide demonstrated the potential for once-weekly dosing. BASEL, Switzerland , Oct.

Medicine 52

Medicine Business Development Development Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

Drugs 147

Drugs Medicine Marketing Development 147

Pharmaceutical Technology

SEPTEMBER 8, 2022

Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector. . • Formulation.

Marketing 130

Marketing Pharmacy Containment Sales 130

XTalks

FEBRUARY 14, 2024

This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. OncoC4 is a spinout of OncoImmune, which was acquired by Merck in December 2020.

Life Science 119

Life Science DNA Production Clinical Trials 119

pharmaphorum

JULY 1, 2022

Blueprint Medicines has taken an unusual route to raising cash for its R&D pipeline – selling off some of the royalties from its already-approved medicines in return for a cash injection of up to $1.25 Blueprint is drawing $150 million of that straight away. billion if needed.

Business Development 52

Business Development Medicine Sales Marketing 52

Camargo

SEPTEMBER 23, 2020

Thomas Kassberg, Chief Business Officer, Ultragenyx. The panelists brought diverse perspectives on the future of orphan drug development, how their companies evaluate new potential products and partnering opportunities, and how they are working to address challenges like clinical study design and patient recruitment. Marketing Manager.

Business Development 136

Business Development Drugs Development Production 136

Drug Discovery World

DECEMBER 21, 2022

million (US$2 million) from Innovate UK’s Biomedical Catalyst 2022 funding competition, to accelerate development of a first-in-class disease modifying therapy for Huntington’s disease. . This latest funding from Innovate UK will enable us to accelerate development of our antibody and deliver some hope for patients.” . The post £1.7M

Antibody 52

Antibody Clinical Trials Clinical Trials Business Development 52

Drug Discovery World

NOVEMBER 30, 2023

Kimryn Rathmell has been chosen as the 17 th director of the National Cancer Institute (NCI), bringing her experience as leader of the Department of Medicine at the Vanderbilt University Medical Center and Physician-in-Chief at the Vanderbilt University Adult Hospital and Clinics.

Drugs 52

Drugs Genome Genomics Bioinformatics 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development. Technologies in the delivery of peptides and proteins.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. The emergence of expensive new speciality medicines are also expected to impact business models in future.

Pharmacy 113

Pharmacy Containment Manufacturing Business Development 113

BioTech 365

SEPTEMBER 28, 2020

.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the promotion of Abbas Kazimi to Chief Business Officer.

Business Development 52

Business Development Medicine Development Drugs 52

Drug Discovery World

SEPTEMBER 2, 2022

Raj Patey, Business Development Director, MyGreenLabs, will be discussing The Sustainable Lab: Building a Global Culture of Sustainability in Science. . Raj Patey, Business Development Director, MyGreenLabs. The role of AI and automation in personalised medicine: How can AI help in the post drug discovery process .

Drugs 52

Drugs Business Development Development Medicine 52

XTalks

MAY 29, 2024

Vertex launched its cystic fibrosis medicine Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in 2019. The company focuses heavily on its product and business development and prioritizes its environmental and social responsibilities. The Financial Times reported Seagen’s CAGR to be 28.88

Medicine 52

Medicine Marketing FDA Approval Development 52

Pharmaceutical Technology

DECEMBER 22, 2022

Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. Innovation.

Insulin 130

Insulin Production Development Genetics 130

Drug Discovery World

JULY 18, 2022

Biotechnology company Complement Therapeutics has appointed a new member to its board to help support the company with its development goals. . Axon has over 20 years of experience in the industry and is currently the CEO of Glycomine, a clinical-stage company focused on developing new therapies for serious unserved orphan diseases.

Business Development 52

Business Development Development Medicine Drugs 52

pharmaphorum

NOVEMBER 7, 2022

In 2022, she won the CFO of the Year Award in the small business category from the San Diego Business Journal for her leadership in building and managing successful financial teams. ” Patrick Genestin, 1910 Genetics . “I am excited to join 1910 Genetics at such a pivotal time for the company,” Genestin said.

Life Science 106

Life Science Genetics Business Development Marketing 106

Pharmaceutical Technology

APRIL 26, 2023

Electronic respiratory health company Adherium has also developed a digital inhaler system focusing on patient adherence, remote monitoring, and data management. There is also huge potential to use these data to inform future drug development and clinical trials of new asthma medication,” adds Chan.

Clinical Trials 289

Clinical Trials Clinical Trials Allergies Research 289

pharmaphorum

SEPTEMBER 18, 2020

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. .

Gene Editing 105

Gene Editing Gene Vaccination Vaccine 105

The Pharma Data

APRIL 6, 2022

Novartis announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade. ” Integrating Pharmaceuticals and Oncology business units. .

Medicine 52

Medicine Sales Development Marketing 52

Drug Discovery World

JUNE 15, 2023

According to Carole Nicco, Chief Scientific Officer of BioSenic , CGT products, regulated in the EU as Advanced Therapy Medicinal Products (ATMP), are among the fastest growing areas of scientific innovation and business in the life sciences today. The next article will cover redefining manufacturing. eXmoor is optimising the DSP?

Regulation 52

Regulation Production Development Medicine 52

Drug Discovery World

MAY 29, 2024

Dr Neela Patel, Chief Business Officer at Bonum Therapeutics, offers advice on how to negotiate a winning deal in biopharma that meets investors’, buyers’ and sellers’ goals. Does one side strongly desire an asset purchase or acquisition, while the other side prefers a co-development or co-commercialisation transaction?

Scientist 59

Scientist Licensing Licensing Development 59

The Pharma Data

JUNE 7, 2023

a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. “Adding Acuitas’ clinically-validated and scalable LNP technology to our genomic medicine toolbox is another important step to advance our leadership in the field of cell and gene therapies.”

Gene Therapy 40

Gene Therapy Gene Gene Editing In-Vivo 40

Pharmaceutical Technology

JUNE 19, 2023

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide. The requirements When handling personalised medicines, time is of the essence.

Gene Therapy 130

Gene Therapy Gene Packaging Packaging 130

The Pharma Data

AUGUST 17, 2021

Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience and immunology business units. These changes will increase Lilly’s focus on introducing breakthrough new medicines to millions of people with unmet needs. Ricks, Lilly’s chairman and CEO. except for Canada.

Medicine 52

Medicine Dermatology Production Development 52

pharmaphorum

FEBRUARY 1, 2022

His research focuses on the development of big data machine learning for tracking the health of complex systems. He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Engineer 105

Drug Discovery World

JUNE 16, 2023

Our partners are leading companies (Conveyxo, Exo Biologics, Livedrop, Genflow Biosciences, Orgenesis, Theracell Advanced Biotechnology, Cylix Group) for each step of the production of ATMPs, which will then be developed and clinically evaluated by BioSenic.

Manufacturing 52

Manufacturing In-Vivo Production Compliance 52